Synthaverse S.A. (SVE.WA)

PLN 4.28

(7.0%)

Eps Summary of Synthaverse S.A.

Synthaverse S.A.'s latest annual eps in 2023 was 0.07 PLN , down -24.78% from previous year.
Synthaverse S.A.'s latest quarterly eps in 2024 Q2 was 0.02 PLN , up 458.93% from previous quarter.
Synthaverse S.A. reported an annual eps of 0.09 PLN in 2022, up 28.57% from previous year.
Synthaverse S.A. reported an annual eps of 0.07 PLN in 2021, down -1.82% from previous year.
Synthaverse S.A. reported a quarterly eps of 0.02 PLN for 2024 Q2, up 458.93% from previous quarter.
Synthaverse S.A. reported a quarterly eps of 0.06 PLN for 2023 Q4, up 260.17% from previous quarter.

Annual Eps Chart of Synthaverse S.A. (2023 - 2010)

Historical Annual Eps of Synthaverse S.A. (2023 - 2010)

Year	Eps	Eps Growth
2023	0.07 PLN	-24.78%
2022	0.09 PLN	28.57%
2021	0.07 PLN	-1.82%
2020	0.07 PLN	78.7%
2019	0.04 PLN	107.39%
2018	-0.54 PLN	-640.0%
2017	0.10 PLN	118.87%
2016	-0.53 PLN	36.9%
2015	-0.84 PLN	-32407.69%
2014	0.00 PLN	-91.33%
2013	0.03 PLN	121.43%
2012	-0.14 PLN	-1129.41%
2011	0.01 PLN	-83.0%
2010	0.08 PLN	0.0%

Year	Eps	Eps Growth
2024 Q1	-0.01 PLN	-110.16%
2024 Q2	0.02 PLN	458.93%
2023 Q4	0.06 PLN	260.17%
2023 Q3	-0.03 PLN	-194.25%
2023 Q2	0.04 PLN	244.34%
2023 FY	- PLN	-24.78%
2023 Q1	0.01 PLN	-73.5%
2022 Q4	0.04 PLN	70.21%
2022 Q3	0.02 PLN	-46.1%
2022 Q2	0.04 PLN	475.86%
2022 Q1	-0.01 PLN	-123.2%
2022 FY	- PLN	28.57%
2021 Q1	-0.02 PLN	-131.67%
2021 Q2	0.05 PLN	363.16%
2021 Q3	-0.01 PLN	-118.0%
2021 FY	- PLN	-1.82%
2021 Q4	0.05 PLN	655.56%
2020 Q4	0.06 PLN	3900.0%
2020 FY	- PLN	78.7%
2020 Q1	0.02 PLN	0.0%
2020 Q2	-0.01 PLN	-134.0%
2020 Q3	0.00 PLN	122.06%
2019 FY	- PLN	107.39%
2019 Q1	0.00 PLN	100.67%
2019 Q2	0.01 PLN	103.03%
2019 Q3	0.01 PLN	-16.42%
2019 Q4	0.02 PLN	257.14%
2018 Q4	-0.49 PLN	-4800.0%
2018 Q3	-0.01 PLN	25.93%
2018 Q2	-0.01 PLN	-60.71%
2018 Q1	-0.01 PLN	-104.0%
2018 FY	- PLN	-640.0%
2017 Q3	0.00 PLN	100.5%
2017 FY	- PLN	118.87%
2017 Q4	0.21 PLN	17400.0%
2017 Q2	-0.24 PLN	-1400.0%
2017 Q1	-0.02 PLN	93.33%
2016 Q3	-0.07 PLN	67.23%
2016 Q4	-0.24 PLN	-232.87%
2016 FY	- PLN	36.9%
2016 Q1	-0.01 PLN	98.65%
2016 Q2	-0.22 PLN	-2100.0%
2015 Q2	-0.01 PLN	84.28%
2015 Q3	-0.04 PLN	-422.5%
2015 FY	- PLN	-32407.69%
2015 Q4	-0.74 PLN	-1670.33%
2015 Q1	-0.05 PLN	-196.77%
2014 Q3	-0.05 PLN	-23900.0%
2014 FY	- PLN	-91.33%
2014 Q1	0.00 PLN	-75.0%
2014 Q2	-0.00 PLN	-166.67%
2014 Q4	0.05 PLN	209.58%
2013 Q4	0.00 PLN	-95.9%
2013 Q2	0.00 PLN	-70.5%
2013 Q3	0.03 PLN	614.63%
2013 Q1	0.01 PLN	112.64%
2013 FY	- PLN	121.43%
2012 Q4	-0.11 PLN	-249.21%
2012 FY	- PLN	-1129.41%
2012 Q2	-0.01 PLN	-184.71%
2012 Q3	-0.03 PLN	-337.5%
2012 Q1	0.01 PLN	0.0%
2011 FY	- PLN	-83.0%
2010 FY	- PLN	0.0%

Peer Eps Comparison of Synthaverse S.A.

Name	Eps	Eps Difference
Bioceltix S.A.	-3.49 PLN	101.94%
BIOTON S.A.	0.03 PLN	-155.472%
Captor Therapeutics Spolka Akcyjna	-15.19 PLN	100.446%
Mabion S.A.	2.55 PLN	97.345%
Molecure S.A.	-1.09 PLN	106.211%
NanoGroup S.A.	-0.39 PLN	117.359%
Pharmena S.A.	2.60 PLN	97.396%
Poltreg S.A.	-2.91 PLN	102.326%
Pure Biologics Spólka Akcyjna	-11.19 PLN	100.605%
Ryvu Therapeutics S.A.	-4.02 PLN	101.684%
Urteste S.A.	-4.32 PLN	101.567%